Contact UsTwo Pershing Square 2300 Main Street, Suite 170 Kansas City MO 64108
Two Pershing Square
2300 Main Street, Suite 170
Kansas City, MO 64108
Telephone: (816) 221-6600
Toll Free: 1 (877) 284-6600
Fax: (816) 221-6612
It’s never an easy decision to put a loved one in a nursing home or other assisted living facility. You want to make sure your elderly parent, grandparent or other loved one receives the best care possible.
Car crashes are the number one killer of teens in the United States and a leading cause of death in countries around the world. Youth-led campaigns like Global Youth Traffic Safety Month (GYTSM) promote safe teen driving through a peer-to-peer model.
The warm weather means BBQs, swim parties and many other fun activities and celebrations, often involving alcoholic beverages â€¦ leading to inebriated drivers on our Kansas City roadways.
Biking is a popular activity in many areas, especially the Kansas City area. More and more people are riding bikes rather than driving as well as for exercise or just the sheer enjoyment.
From 2000 to 2012 there was a 64% increase in cyclists traveling to work, according to the NHTSA.
Warmer weather is always a draw for those who love to ride motorcycles. And, of course, driving a car and driving a motorcycle requires different skills and knowledge. As a driver, what do you need to know about sharing the road with motorcyclists?
In a March 31, 2017 ruling, Zimmer was ordered to pay more than $2 million to a New Mexico man for a defective hip implant with an “unreasonably dangerous design.”
In 2016, 3.2 trillion miles were driven on U.S. roads. Is it any wonder that, on average, each year there are 6,000,000 motor vehicle accidents occurring?
A growing number of Proton Pump Inhibitor (PPI) lawsuits have been filed against the manufacturers of PPI medications. Plaintiffs allege that as a result of taking a PPI for gastric acid-related conditions, they have been diagnosed with kidney injuries including Acute Interstitial Nephritis (AIN), chronic kidney disease and renal failure.
Originally scheduled to start in February, the first Bellwether trial for the blood thinner, Xarelto, will now begin on April 24, 2017 in the Eastern District of Louisiana.
Products such as new drugs and complex medical devices must be proven safe and effective before companies can put them on the market.